Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong · Delayed Price · Currency is HKD 58.75
+2.50 (4.44%)
Apr 20, 2026, 4:08 PM HKT
HKG:6609 Revenue
In the year 2025, Shanghai HeartCare Medical Technology Corporation had annual revenue of 408.29M CNY with 46.92% growth. Shanghai HeartCare Medical Technology Corporation had revenue of 222.76M in the half year ending December 31, 2025, with 81.47% growth.
Revenue
408.29M CNY
Revenue Growth
+46.92%
P/S Ratio
4.90
Revenue / Employee
1.11M CNY
Employees
368
Market Cap
2.22B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 408.29M | 130.39M | 46.92% |
| Dec 31, 2024 | 277.90M | 45.56M | 19.61% |
| Dec 31, 2023 | 232.34M | 49.31M | 26.94% |
| Dec 31, 2022 | 183.03M | 92.94M | 103.17% |
| Dec 31, 2021 | 90.09M | 75.53M | 518.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Isotope & Radiation | 8.00B |
| Sisram Medical | 2.84B |
| Gaush Meditech | 1.54B |
| Peijia Medical | 793.29M |
| MicroTech Medical (Hangzhou) | 735.33M |
| Acotec Scientific Holdings | 717.35M |
| LEPU ScienTech Medical Technology (Shanghai) | 587.50M |
| MicroPort CardioFlow Medtech | 444.00M |